These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 20456688)
1. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil. Yürek S; Riess H; Kreher S; Dörken B; Salama A Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688 [TBL] [Abstract][Full Text] [Related]
2. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Arndt P; Garratty G; Isaak E; Bolger M; Lu Q Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254 [TBL] [Abstract][Full Text] [Related]
3. Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody. Arndt PA; Garratty G; Brasfield FM; Vemuri SL; Asuncion DJ Transfusion; 2010 Feb; 50(2):302-7. PubMed ID: 19874564 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer. Chen ML; Fang CH; Liang LS; Dai LH; Wang XK Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093 [TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605 [TBL] [Abstract][Full Text] [Related]
7. [A case report: successful resection of advanced intrahepatic cholangiocarcinoma responding to preoperative hepatic artery infusion of 5-FU]. Hasuike Y; Motoori M; Hattori T; Fujita J; Mishima H; Sawamura T; Nishishou I; Kikkawa N; Sai H; Hosoki T; Mitomo M Gan To Kagaku Ryoho; 1999 Oct; 26(12):1909-12. PubMed ID: 10560423 [TBL] [Abstract][Full Text] [Related]
8. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method. Arndt PA; Garratty G; Hill J; Kasper M; Chandrasekaran V Vox Sang; 2002 Oct; 83(3):273-8. PubMed ID: 12366773 [TBL] [Abstract][Full Text] [Related]
10. Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients. Bensmaïne MA; Marty M; de Gramont A; Brienza S; Lévi F; Ducreux M; François E; Gamelin E; Bleiberg H; Cvitkovic E Br J Cancer; 2001 Aug; 85(4):509-17. PubMed ID: 11506488 [TBL] [Abstract][Full Text] [Related]
11. [A case of successful management of advanced cholangiocellular carcinoma by repeated hepatic resection]. Nakano H; Sasaki Y; Imaoka S; Furukawa H; Ishikawa O; Kabuto T; Kameyama M; Hiratsuka M; Ohigashi H; Nakamori S; Yasuda T; Iwanaga T Gan To Kagaku Ryoho; 1996 Sep; 23(11):1603-6. PubMed ID: 8854817 [TBL] [Abstract][Full Text] [Related]
12. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells. Broadberry RE; Farren TW; Bevin SV; Kohler JA; Yates S; Skidmore I; Poole J; Garratty G Transfus Med; 2004 Feb; 14(1):53-7. PubMed ID: 15043594 [TBL] [Abstract][Full Text] [Related]
13. [Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma]. Yokoo H; Kamiyama T; Nakagawa T; Nakanishi K; Tahara M; Fukumori D; Kamachi H; Matsushita M; Todo S Gan To Kagaku Ryoho; 2009 Nov; 36(12):2400-3. PubMed ID: 20037436 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
15. [Cases of advanced cholangiocarcinoma showing partial response by the combination chemotherapy including protracted continuous infusion of 5-FU combined with intravenous administration of low-dose leucovorin and intra-arterial administration of MMC and CQ]. Tsushima K; Sakata Y; Shiratori Y; Sakamoto J; Koeda J; Yamada Y; Soma N; Tamura K; Yoshiwara A; Soma Y Gan To Kagaku Ryoho; 1991 Dec; 18(15):2603-5. PubMed ID: 1660702 [TBL] [Abstract][Full Text] [Related]
16. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. Liu ZF; Guo QS; Zhang XQ; Yang XG; Guan F; Fu Z; Wang MY Am J Clin Oncol; 2008 Jun; 31(3):259-63. PubMed ID: 18525305 [TBL] [Abstract][Full Text] [Related]
17. An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248 [TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer. Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759 [TBL] [Abstract][Full Text] [Related]
19. [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy]. Uchiyama K; Takada T; Yasuda H; Hasegawa H; Tsuchiya S; Misu Y; Saitoh Y; Shikata J; Kozakai M Gan To Kagaku Ryoho; 1988 Jun; 15(6):1987-90. PubMed ID: 3132897 [TBL] [Abstract][Full Text] [Related]
20. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma. Kallen KJ; Hofmann MA; Timm A; Gödderz W; Galle PR; Heike M Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]